French | English

As a preferred partner for hospital specialists, BioAlliance Pharma is a company that conceives and develops innovative products in the treatment of cancer and AIDS, as well as in supportive care. We market our products in France directly and through industrial partners in the rest of the world. Our targeted approaches, in areas where medical needs are insufficiently met, contribute to overcoming drug resistance and improving health and quality of life for patients. BioAlliance Pharma’s ambition is to become a leading player in these fields by coupling innovation with patients’ needs.

Consolidated results 2009 BioAlliance Pharma has published its consolidated results for 2009. You can access the presentation made on March 4, 2010 during the Financial Analysts Meeting.
Agenda